Palvella Therapeutics (PVLA) Receivables - Net (2013 - 2024)
Palvella Therapeutics (PVLA) posted Receivables - Net of $358,000 for Q4 2024, down 4.0% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Receivables - Net (2013 - 2024) Analysis & Trends
Since Q4 2013, Palvella Therapeutics has reported Receivables - Net for 35 quarters.
- Annual Receivables - Net shows a five-year compound annual growth rate of -44.5% (FY2019 to FY2024).
- In prior years, Palvella Therapeutics' Receivables - Net was $5.81 million in FY2022 (+75.4%), $3.31 million in FY2021 (+94.2%) and $1.71 million in FY2020 (-74.9%).
- The Q4 2024 figure stands as the lowest quarterly Receivables - Net since Q1 2017.
- On a year-over-year basis, Receivables - Net increased in three of the last six quarters, with growth averaging 5.3%.
- The strongest year-over-year quarter for Receivables - Net in the past five years was Q3 2021, with growth of 125.7%; the weakest was Q1 2022, with a decline of 89.6%.
- According to Business Quant data, Receivables - Net for the three prior quarters was $373,000 (Q3 2024), $1.49 million (Q2 2024) and $1.84 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Palvella Therapeutics | 1.77 Bn | 1.52 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 358,000.00 |
| Sep 30, 2024 | 373,000.00 |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.84 Mn |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 952,000.00 |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 5.81 Mn |
| Sep 30, 2022 | 829,000.00 |
| Jun 30, 2022 | 1.26 Mn |
| Mar 31, 2022 | 1.64 Mn |
| Dec 31, 2021 | 3.31 Mn |
| Sep 30, 2021 | 6.65 Mn |
| Jun 30, 2021 | 2.80 Mn |
| Mar 31, 2021 | 15.81 Mn |
| Dec 31, 2020 | 1.71 Mn |
| Sep 30, 2020 | 2.94 Mn |
| Jun 30, 2020 | 10.71 Mn |
| Mar 31, 2020 | 7.27 Mn |
| Dec 31, 2019 | 6.79 Mn |
API Access
Palvella Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();